Analyst Ratings for CVS Health (CVS)
CVS Rating Summary
CVS Price Target Summary
- Highest: $123.00 (Wells Fargo)
- Lowest: $84.00 (Nephron)
- Average: $109.47
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$109.47 (+18.5%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
Avg. $ Target:
$109.47 (+18.5%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2026 | Nephron | Eric Percher | New Coverage | Hold (N/A) |
84.00 (N/A) |
77.30 (92.36) |
19.48% | Details |
| 3/12/2026 | Bernstein SocGen Group » Updated 9/9/2026 |
Lance Wilkes | Upgrade | Outperform (Market Perform) |
112.00 (106.00) |
75.72 (92.36) |
21.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
